title: Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715.
abstract: The use of cytotoxic drug vincristine (VCR) is limited by the occurrence of peripheral neuropathy. A neurotrophic ACTH(4-9) analogue, ORG 2766, is being studied for its protective effect. Possible modulatory effects of ORG 2766 on tumour cell growth and interference with the cytotoxic efficacy of VCR were studied in two human lymphoma cell lines, U937 and U715. The effects of ORG 2766 on cell growth and survival and on VCR-mediated cytotoxicity were investigated using two MTT-based assays to study direct cytotoxic effects and to assess residual growth after pretreatment. Treatment with ORG 2766 alone had no effect on cell growth and survival. Neither did this drug affect VCR cytotoxicity. However, after 96 h pretreatment with ORG 2766 and a culture period of 7 days, a reduction in residual growth and a potentiation of VCR-induced inhibition of growth capacity was observed in U715 cells, and to some extent also in U937 cells. It is concluded that ORG 2766 has no stimulatory effects on tumour growth and does not negatively interfere with VCR-mediated cytotoxicity. Rather it enhances the cytostatic effect of VCR. It is suggested that ORG 2766 can safely be used in clinical trials investigating the ability of ORG 2766 to counteract VCR-induced neurotoxicity.
authors.affiliation: Department of Neurology, Free University Hospital, Amsterdam, The Netherlands.
authors.forename: B
authors.initials: B
authors.lastname: Kiburg
authors.forename: A A
authors.initials: AA
authors.lastname: van de Loosdrecht
authors.forename: K M
authors.initials: KM
authors.lastname: Schweitzer
authors.forename: G J
authors.initials: GJ
authors.lastname: Ossenkoppele
authors.forename: L J
authors.initials: LJ
authors.lastname: Müller
authors.forename: J J
authors.initials: JJ
authors.lastname: Heimans
authors.forename: P C
authors.initials: PC
authors.lastname: Huijgens
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007700:Kinetics; D016393:Lymphoma, B-Cell; D016403:Lymphoma, Large B-Cell, Diffuse; D010446:Peptide Fragments / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D014750:Vincristine / Q000633:toxicity*
chemical_list: D000927:Anticonvulsants; D010446:Peptide Fragments; C013765:Org 2766; D014750:Vincristine; D000324:Adrenocorticotropic Hormone